Patent · US Active

Compounds

US7553849B2 · kind B2 · utility

1Cited by

1References

21Claims

0Family size

Assignee

Active Biotech AB · SE

Inventors

Anders Bjork · Bjärred, SE
Karl Jansson · Dalby, SE

Key dates

Filing date	Jun 15, 2005
Grant date	Jun 30, 2009
Priority date	—
Expiry date	Dec 21, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P37/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A compound of formula (I)wherein A pharmaceutical composition comprising a compound of formula (I), a method of treating malignant tumours or diseases resulting from autoimmunity or pathologic inflammation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.